T. Schulz-Utermoehl
Department of Drug Metabolism
Novo Nordisk A/S
Novo Nordisk Park
Maaloev
Denmark
Name/email consistency: medium
- Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody. Schulz-Utermoehl, T., Mountfield, R.J., Madsen, K., Jørgensen, P.N., Hansen, K.T. Drug Metab. Dispos. (2000)
- Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody. Schulz-Utermoehl, T., Mountfield, R.J., Bywater, R.P., Madsen, K., Jørgensen, P.N., Hansen, K.T. Drug Metab. Dispos. (2000)









